Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-854-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 - 25 April
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- missing 5th strain (TA 102 or E. coli WP2)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted May 26, 1983
- Deviations:
- yes
- Remarks:
- missing 5th strain (TA 102 or E. coli WP2)
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5265 (The Salmonella typhimurium Bacterial Reverse Mutation Test)
- Version / remarks:
- Sep 1985
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Fatty acids C16-18 (even numbered), mono and di esters with Sucrose
- EC Number:
- 947-854-9
- Molecular formula:
- not applicable, substance is UVCB
- IUPAC Name:
- Fatty acids C16-18 (even numbered), mono and di esters with Sucrose
Constituent 1
Method
- Target gene:
- his operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of male rats treated with Aroclor 1254 (500 mg/kg bw)
- Test concentrations with justification for top dose:
- 4, 20, 100, 500, 2500 and 5000 µg/plate with and without metabolic activation
- Vehicle / solvent:
- - Vehicle/solvent used: DMSO
- Justification for choice of solvent/vehicle: Test substance is well soluble in DMSO at approx. 48 °C and is stabil for 4 h.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- other: 2-Aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: triplicates in 2 different experiments
DETERMINATION OF CYTOTOXICITY
- Method: reduction in the number of colonies or a thinning of the bacterial background lawn - Evaluation criteria:
- A test compound is classified as mutagenic if it has either of the following effects:
a) a test compound produces at least a 2-fold increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of
revertants per plate of the appropriate vehicle control at complete bacterial background lawn
b) a test compound induces a dose-related increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of
revertants per plate of the appropriate vehicle control in at least two to three concentrations of the test compound at complete bacterial background lawn.
lf the test substance does not produce reproducible increases of at least 2 times the concurrent solvent controls, at any dose level with any bacterial strain, it is considered to show no evidence of mutagenic activity in this system.
The test results must be reproducible. - Statistics:
- Mean values and standard deviations were calculated.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Exp 1: +S9: at and above 2500 µg/plate; -S9: at and above 500 µg/plate Exp 2: +S9: at and above 500 µg/plate; -S9: at and above 100 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Exp 1: +S9: at and above 2500 µg/plate; -S9: at and above 100 µg/plate Exp 2: +/- S9: at and above 500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Exp 1 and 2: +S9: at and above 2500 µg/plate; -S9: at and above 500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Exp 1: +S9: at and above 5000 µg/plate; -S9: at and above 500 µg/plate Exp 2: +/- S9: at and above 2500 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Visible precipitation of the test substance was observed at 2500 µg/plate and above in both experiments.
RANGE-FINDING/SCREENING STUDIES: In a toxicity test with a dilution of tester strain TA 100, which was performed in parallel with the second experiment, toxicity was found at a concentration of 2500 μg/plate in the presence of metabolic activation and 100 μg/plate in the absence of metabolic activation.
ADDITIONAL INFORMATION ON CYTOTOXICITY: In both mutagenicity experiments strain dependent cytotoxicity was observed in a dose range of 100 to 2500 μg/plate and above without metabolic activation and in a dose range of 500 to 5000 μg/plate withmetabolic activation. Thinning of bacterial
lawn and in most cases also a reduction in the number of colonies were observed at these doses.
Any other information on results incl. tables
Table 1: Results of Experiment 1
|
Number of revertant colonies (mean of 3 plates±SD) |
|||||
With S9 |
||||||
Test substance (µg/plate) |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
||
Solvent control |
10.7±1.2 |
14.7±1.2 |
26.7±5.5 |
115.3±5.0 |
||
Negative control (untreated) |
10.3±1.5 |
17.0±4.6 |
22.3±1.5 |
148.3±4.0 |
||
0 |
10.7±1.2 |
14.7±1.2 |
26.7±5.5 |
115.3±5.0 |
||
4 |
13.3±1.5 |
14.3±2.5 |
26.7±4.7 |
123.7±6.7 |
||
20 |
11.7±3.5 |
14.3±1.5 |
21.0±1.7 |
132.7±8.0 |
||
100 |
9.3±2.3 |
13.0± 1.0 |
22.7±2.1 |
126.0±2.6 |
||
500 |
9.7±0.6 |
14.7±3.5 |
19.7±2.5 |
121.7±3.2 |
||
2500 |
7.0±1.7 r |
2.7±1.2 r |
16.3±6.7 r |
93.3±10.1 |
||
500 |
3.0±2.0 r |
1.0±0.0 c |
8.3±2.5 r |
102.0±15.6 r |
||
Positive Control |
2-AA |
2-AA |
2-AA |
2-AA |
||
Dose (µg/plate) |
1.0 µg/plate |
1.0 µg/plate |
0.5 µg/plate |
0.5 µg/plate |
||
Number of revertant colonies/plate |
194.3±9.3 |
288.7±33.2 |
2211.7±0.5 |
1757.7±69.6 |
||
Without S9 |
||||||
Test substance (µg/plate) |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
||
Solvent control |
8.3±0.6 |
12.0±2.0 |
19.7±3.2 |
116.3±15.3 |
||
Negative control (untreated) |
11.7±0.6 |
12.7±1.2 |
25.0±3.6 |
119.3±15.2 |
||
0 |
8.3±0.6 |
12.0±2.0 |
19.7±3.2 |
116.3±15.3 |
||
4 |
12.7±0.6 |
8.3±3.1 |
22.7±2.9 |
107.7±11.9 |
||
20 |
10.3±2.9 |
8.0±3.0 |
19.3±2.5 |
129.0±17.6 |
||
100 |
9.7±2.1 |
5.0±3.6 r |
21.3±2.9 |
117.0±5.3 |
||
500 |
10.0±2.0 r |
5.0±1.7 r |
12.7±2.1 r |
83.7±7.6 |
||
2500 |
1.7±0.6 r |
2.7±1.2c |
6.3±0.6 r |
93.0±9.5 |
||
5000 |
1.3±0.6 r |
1.0±0.0 c |
6.7± 3.1 c |
83.3±14.4 r |
||
Positive Control |
NaN3 |
9-AA |
2-NF |
NaN3 |
||
Dose (µg/plate) |
2.5 |
2.5 |
2.5 |
2.5 |
||
Number of revertant colonies/plate |
461.3±2.3 |
150.7±43.1 |
564.3±67.5 |
636.3±10.1 |
||
2AA: 2-Aminoanthracene 9-AA: 9-Aminoacridine 2-NF: 2-Nitrofluorene NaN3: sodium azide |
r: reduced background growth c: clearing of background growth |
Table 2. Results of Experiment 2
|
Number of revertant colonies (mean of 3 plates±SD) |
|||
With S9 |
||||
Test substance (µg/plate) |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
Solvent control |
12.3±1.2 |
9.7±2.5 |
31.3±5.1 |
130.3±0.6 |
Negative control (untreated) |
12.3±1.5 |
10.3±0.6 |
26.0±2.6 |
163.3±13.3 |
0 |
12.3±1.2 |
9.7±2.5 |
31.3±5.1 |
130.3±0.6 |
4 |
9.3±7.6 |
9.0±1.0 |
32.7±6.5 |
137.7±12.4 |
20 |
8.3±5.5 |
8.3±1.2 |
23.7±2.1 |
139.0±11.5 |
100 |
10.7±3.1 |
10.3±3.2 |
28.0±3.0 |
149.3±5.1 |
500 |
12.3±2.9 r |
4.3±2.5 r |
30.3±12.1 |
143.7±10.1 |
2500 |
6.3±2.9 r |
3.0±1.7 r |
12.3±2.1 r |
129.7±0.6 r |
500 |
6.3± 6.7 r |
2.0±1.0 c |
10.3±1.2 r |
135.3±14.2 r |
Positive Control |
2-AA |
2-AA |
2-AA |
2-AA |
Dose (µg/plate) |
1.0 µg/plate |
1.0 µg/plate |
0.5 µg/plate |
0.5 µg/plate |
Number of revertant colonies/plate |
172.7±13.1 |
272.3±13.8 |
2199.7±150.5 |
1897.7±114.2 |
Without S9 |
||||
Test substance (µg/plate) |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
Solvent control |
13.7±0.6 |
8.0±0.0 |
20.3±1.2 |
130.3±0.6 |
Negative control (untreated) |
13.7±2.1 |
7.3±1.2 |
26.0±4.4 |
163.3±13.3 |
0 |
13.7±0.6 |
8.0±0.0 |
20.3±1.2 |
125.3±15.9 |
4 |
11.0±2.6 |
7.0±1.0 |
24.0±1.7 |
129.3±7.0 |
20 |
9.0±1.7 |
8.3±1.2 |
24.3±1.2 |
124.0±8.2 |
100 |
11.3±3.1 r |
7.0±1.0 |
26.7±3.8 |
123.7±23.6 |
500 |
11.3±2.5 r |
2.3±0.6 r |
13.0±2.6 r |
105.3±19.5 |
2500 |
1.7±1.5 r |
1.3±0.6 c |
6.7±0.6 r |
95.0±3.6 r |
5000 |
0.3±0.6 r |
1.0±0.0 c |
5.0±1.0 r |
83.0±7.9 r |
Positive Control |
NaN3 |
9-AA |
2-NF |
NaN3 |
Dose (µg/plate) |
2.5 |
2.5 |
2.5 |
2.5 |
Number of revertant colonies/plate |
431.3±55.0 |
215.3±33.1 |
520.3±89.2 |
1897.7±114.2 |
2AA: 2-Aminoanthracene 9-AA: 9-Aminoacridine 2-NF: 2-Nitrofluorene NaN3: sodium azide |
r: reduced background growth c: clearing of background growth |
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions used, the substance was not mutagenic in any of the four strains of Salmonella typhimurium (TA 1535, TA 1537, TA 98 and TA 100) tested with and without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.